Glycyphagus Domesticus (Furniture Mite): The 89.5% Sensitization Storage Mite
Glycyphagus domesticus, the furniture mite, achieved a striking 89.5% sensitization rate among 138 consecutive rhinoconjunctivitis and asthma patients in Northern Spain β the highest single-species storage mite sensitization rate reported. Its major allergen Gly d 2 (NPC2 family) shares only about 40% identity with Der p 2, making HDM immunotherapy unreliable coverage. Unlike other storage mites, it inhabits home upholstery and carpets rather than food products, making it a true domestic allergen requiring independent diagnosis and immunotherapy.
Free Β· 5 min Β· Insurance accepted
Key facts
Glycyphagus domesticus achieved 89.5% sensitization in 138 consecutive rhinoconjunctivitis and asthma patients in Northern Spain β the highest single-species storage mite rate reported.
Gly d 2 (NPC2 family) shares only ~40% amino acid identity with Der p 2 β below the cross-reactivity threshold, so HDM immunotherapy does not reliably cover G. domesticus sensitization.
Maintaining indoor humidity below 50% reduces house dust mite populations by over 10-fold β the same principle applies to G. domesticus in upholstered furniture.
Unlike food storage mites, G. domesticus inhabits home upholstery and carpets, making humidity control in living rooms the primary avoidance strategy.
What Is Glycyphagus Domesticus?
Glycyphagus domesticus β commonly called the furniture mite, sugar mite, or house mite β is a storage mite belonging to the family Glycyphagidae.
Despite being classified taxonomically as a storage mite, G. domesticus occupies a unique ecological niche among its storage mite relatives: instead of infesting food products like grain or cheese, it inhabits domestic soft furnishings β upholstered furniture, carpets, stored textiles, and damp walls β in humid indoor environments. This domestic habitat makes it a perennial exposure source in homes, particularly in coastal and maritime climates where indoor humidity regularly exceeds 65%.
A landmark Northern Spain study found G. domesticus sensitization in 89.5% of 138 consecutive rhinoconjunctivitis and asthma patients β the highest storage mite sensitization prevalence reported for any single species in a clinical cohort.
Its major allergen Gly d 2 (NPC2 family) shares greater than 80% identity with Lep d 2 (Lepidoglyphus destructor allergen) but only approximately 40% identity with the dominant HDM allergen Der p 2 β below the threshold for reliable IgE cross-reactivity, which means HDM immunotherapy does not adequately cover G. domesticus sensitization. Correct diagnosis requires specifically testing for this mite, as it is not included in standard allergy panels.
Symptoms of Glycyphagus Domesticus Allergy
Recognizing symptoms early helps you get the right treatment faster.
Perennial allergic rhinitis
moderateYear-round nasal congestion, sneezing, and rhinorrhea from sustained indoor G. domesticus allergen exposure in household furnishings, often worst in the morning and autumn/winter.
Allergic conjunctivitis
mildRed, itchy, watering eyes from airborne G. domesticus allergen particles, typically bilateral and correlated with household rather than outdoor activities.
Allergic asthma
severeRecurrent wheezing, chest tightness, and dyspnea triggered by indoor G. domesticus allergen inhalation, with the characteristic perennial pattern of HDM-driven asthma.
Nocturnal cough
moderatePersistent dry or mildly productive cough worst at night and on rising, from overnight contact with allergen-laden upholstered furniture and bedding.
Postnasal drip
mildExcess mucosal secretion draining from the nasal passages to the throat, causing frequent throat clearing, hoarseness, and sleep-disrupting coughing.
Atopic dermatitis flares
moderateWorsening of eczema following contact with upholstered furniture harboring G. domesticus, through direct skin contact with allergen-laden fabric surfaces.
When to see a doctor
G. domesticus allergy presents clinically as perennial allergic rhinoconjunctivitis and asthma β indistinguishable in symptom character from Dermatophagoides HDM allergy. Perennial nasal congestion, sneezing, postnasal drip, and itchy watery eyes are the dominant rhinoconjunctivitis symptoms. Asthmatic patients experience wheezing, chest tightness, nocturnal cough, and exertional dyspnea. The critical distinguishing feature of G. domesticus allergy is not the symptoms (which are identical to HDM) but the clinical context: patients whose rhinitis or asthma worsens specifically when using certain pieces of furniture, when cleaning upholstered items, or in specific rooms of the home may have disproportionately high G. domesticus exposure in those settings. Symptoms correlate with indoor humidity seasons β worse in autumn/winter β rather than pollen seasons. Seek emergency care if severe bronchospasm, anaphylaxis, or throat swelling occurs.
Glycyphagus Domesticus and Asthma
G. domesticus is a significant but frequently unrecognized asthma trigger in coastal and maritime climates where it is prevalent. The Northern Spain cohort study that documented 89.5% sensitization among rhinoconjunctivitis and asthma patients is the clearest evidence of its clinical relevance. Unlike Lepidoglyphus destructor β whose major allergen Lep d 2 shows a strong association with asthma (OR=10.4) in epidemiological studies β the specific asthma odds ratios for Gly d 2 have not been as rigorously characterized in large multicenter trials. However, the biological mechanism is identical to HDM asthma: repeated inhalation of G. domesticus allergens drives Th2 airway inflammation, eosinophilic infiltration, and progressive airway hyperreactivity. The critical clinical implication is that asthma patients in Northern Spain, Portugal, the UK, Ireland, and other maritime European regions who fail to respond adequately to HDM immunotherapy may have G. domesticus as an unrecognized primary or co-sensitizer requiring its own immunotherapy coverage.
Complications of Unmanaged G. Domesticus Allergy
The most prevalent complication of G. domesticus allergy is diagnostic and therapeutic misidentification β being tested only with HDM panels, receiving a positive HDM result, and receiving HDM-only immunotherapy that fails to address the G. domesticus sensitization driving the majority of symptoms. Progressive airway remodeling from chronically uncontrolled asthma represents the most serious biological complication. In the Iberian Peninsula context where G. domesticus was most studied, allergists who fail to include this mite in regional sensitization panels miss a major contributor to treatment failure in their HDM-treated asthma patients. New sensitizations from sustained Th2 immune activation represent the standard atopic march complication pathway.
Treatment failure from HDM-only immunotherapy
Patients whose primary sensitizer is G. domesticus (Gly d 2 positive, Der p 2 negative) who receive only HDM immunotherapy experience frustrating treatment failure because they are being desensitized to the wrong allergen.
Progressive airway remodeling
Uncontrolled G. domesticus-driven airway inflammation causes progressive subepithelial fibrosis and smooth muscle hypertrophy, partially irreversible changes that reduce lung function over years.
Missed monosensitized patients
Component-resolved diagnostics found 18.9% of L. destructor-sensitized patients are monosensitized β a proportion expected to be similar for G. domesticus β meaning a substantial fraction are completely missed by HDM-only panels.
How Does Glycyphagus Domesticus Cause Allergy?
G. domesticus causes IgE-mediated Type I allergy through repeated inhalation of mite-derived particles from household soft furnishings.
Furniture mite / Sugar mite
Glycyphagus domesticus
Hay mite
Lepidoglyphus destructor
Cheese mite
Tyrophagus putrescentiae
Grain mite
Acarus siro
How it works
G. domesticus allergy follows the standard IgE-mediated Type I hypersensitivity pathway. The primary allergen Gly d 2 (NPC2 family protein) is presented to mucosal dendritic cells in the respiratory epithelium, driving Th2 polarization, IL-4 and IL-13 release, and specific IgE synthesis by B cells against Gly d 2 and other G. domesticus allergens. On re-exposure, mast cell-bound IgE is cross-linked, triggering histamine, tryptase, and leukotriene degranulation. The Gly d 2 protein structure is homologous to Der p 2 and Lep d 2 (all NPC2 family) but sufficiently distinct at key IgE epitopes to preclude reliable cross-reactive desensitization through HDM immunotherapy.
Because this mite lives in upholstered sofas, chairs, mattresses, and stored textiles rather than food products, exposure occurs through daily domestic activity β sitting on furniture, sleeping in beds, and disturbing textile storage β rather than through occupational handling or food consumption. The mite thrives in humid indoor environments (>65% RH), making coastal, maritime, and humid-climate homes particularly affected.
Mite populations in these environments generate body fragments and fecal material that become airborne during furniture use, penetrate the respiratory epithelium, and drive Th2 sensitization. , Allergo J Int 2022) confirmed that co-positivity for G.
domesticus and HDM represents co-sensitization, not cross-reactivity β the two groups have independent IgE specificities and require separate immunotherapy formulations. Component-resolved diagnostics using Gly d 2 (positive) versus Der p 2 (negative) identifies patients with genuine G.
domesticus monosensitization who would be completely missed by HDM-only testing.
Risk factors to watch for
Coastal or maritime climate
G. domesticus thrives at indoor humidity >65% β homes in coastal, maritime, and high-humidity climates (Northern Spain, Northern Europe, East Asian coastal regions) support the largest domestic populations.
Older upholstered furniture
Aged sofas, armchairs, and mattresses that have accumulated years of organic debris, skin scales, and fungal material provide abundant nutrition and shelter for G. domesticus population establishment.
Poor home ventilation
Homes with poor ventilation that retains humidity in living areas, particularly those with damp walls or inadequate central heating, create the persistently elevated indoor humidity G. domesticus requires.
Pre-existing atopic disease
The atopic immune phenotype (Th2 skewing, elevated total IgE) predisposes individuals to storage mite sensitization; G. domesticus commonly co-sensitizes alongside HDM allergens in atopic patients.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Glycyphagus Domesticus Allergy
Diagnosing G. domesticus allergy requires specifically including this storage mite in the allergy test panel β it is not part of standard Western allergy panels focused on Dermatophagoides species. Clinical suspicion should be raised in patients with: (1) perennial rhinitis or asthma in coastal, maritime, or high-humidity climates; (2) positive HDM testing but inadequate symptom response to HDM-based pharmacotherapy or immunotherapy; (3) furniture-associated symptom correlation β symptoms worsening when sitting on specific upholstered furniture or cleaning carpets. Skin prick testing with G. domesticus extract (wheal β₯3 mm at 15 minutes) or serum specific IgE to G. domesticus whole extract or Gly d 2 component confirms sensitization. The diagnostic refinement comes from component-resolved diagnostics: patients with high Gly d 2 IgE and low Der p 2 IgE represent genuine G. domesticus primary sensitization rather than HDM cross-reactivity β and these patients need G. domesticus-specific immunotherapy. At-home allergy testing services such as Curex can evaluate sensitization to multiple indoor mite species with results within approximately 5 days and insurance coverage accepted, providing an initial sensitization map before specialist component testing.
Skin Prick Test with G. Domesticus Extract
Standardized G. domesticus extract applied by skin prick to the forearm; wheal β₯3 mm at 15 minutes confirms IgE sensitization. Must be specifically requested as it is not in standard Western HDM allergy panels.
Serum Specific IgE (Gly d 2 Component or Whole Extract)
Blood test measuring IgE to G. domesticus whole extract or Gly d 2 (NPC2) component allergen. Component testing is preferred for differential diagnosis against HDM sensitization.
Component-Resolved Diagnostics (Gly d 2 vs Der p 2)
Measuring Gly d 2 specific IgE versus Der p 2 specific IgE differentiates genuine G. domesticus primary sensitization from HDM cross-reactivity, guiding immunotherapy species selection and dosing.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreatment Options for G. Domesticus Allergy
See how different approaches stack up for managing your allergy symptoms long-term.
G. domesticus allergy management integrates allergen avoidance, pharmacotherapy, and species-specific allergen immunotherapy. Environmental controls address the domestic furnishing habitat of this mite: dehumidification below 50% RH in living areas (particularly coastal homes prone to high indoor humidity), regular vacuuming of upholstered furniture with HEPA equipment, and replacement of old upholstered items that have accumulated heavily infested organic debris. Unlike storage mites in food products, there is no dietary component to G. domesticus avoidance. Pharmacotherapy with intranasal corticosteroids and antihistamines controls rhinoconjunctivitis; inhaled corticosteroids and bronchodilators manage asthma. The critical immunotherapy decision mirrors that for other storage mites: the AeDA/DGHNO-KHC position paper recommends that storage mite immunotherapy β including G. domesticus β be pursued independently of HDM treatment, not in expectation of cross-reactive coverage.
Indoor Humidity Reduction
Maintaining indoor humidity below 50-65% with dehumidifiers or improved HVAC halts G. domesticus reproduction in upholstered furniture and carpets. Most important in coastal and maritime homes where outdoor humidity drives persistent indoor elevation.
N/A
Humidity reduction below 50% eliminates mite proliferation; clinical allergen load reduction documented in controlled studies of indoor mite populations
HEPA Vacuuming of Upholstered Furniture
Regular HEPA vacuum cleaning of upholstered sofas, chairs, and carpets removes G. domesticus mites, fecal particles, and body fragments from the surfaces closest to human respiratory exposure.
N/A
HEPA vacuuming reduces surface allergen loads; most effective when combined with humidity control and encasing strategies
Intranasal Corticosteroids
First-line pharmacotherapy for moderate-to-severe G. domesticus rhinitis; controls nasal mucosal inflammation from storage mite allergen inhalation.
Fluticasone (Flonase), mometasone (Nasonex), budesonide (Rhinocort), triamcinolone (Nasacort)
25-40% rhinitis symptom score reduction; superior to antihistamines for congestion control
Custom SLIT Drops (G. Domesticus Formulation)
Custom sublingual immunotherapy drops specifically formulated with G. domesticus extract provide targeted desensitization that HDM-only immunotherapy cannot deliver. The AeDA/DGHNO-KHC position paper recommends this independent SM immunotherapy approach.
Custom sublingual extract drops with Glycyphagus domesticus extract
European evidence from Iberian Peninsula studies supports SM-specific immunotherapy efficacy; AeDA recommends independent G. domesticus immunotherapy from HDM
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy for Glycyphagus Domesticus Allergy
Instead of masking symptoms, immunotherapy retrains your immune system.
Managing G. domesticus allergy with immunotherapy requires the same paradigm shift that applies to all storage mites: standard HDM immunotherapy products are inadequate because of limited allergen cross-reactivity. Gly d 2 and Der p 2 are both NPC2 family proteins β but they share only approximately 40% amino acid identity, below the threshold for significant IgE cross-reactivity. Patients treated with HDM-only ODACTRA or conventional SCIT for confirmed G. domesticus primary sensitization may experience persistent symptoms because their core sensitizing allergen is not included in the treatment formulation. The solution is species-specific immunotherapy formulated with G. domesticus extract. Custom sublingual immunotherapy drops, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), can incorporate G. domesticus extract in a multi-allergen formulation β addressing both G. domesticus and any concurrent HDM sensitization in the same convenient daily at-home administration. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026), clinically meaningful symptom improvement rose to 45% of patients by two years and quality-of-life improvement reached 90.7%, with adherence above 90% and no anaphylaxis reported. For patients in Iberian Peninsula, Northern European, and other maritime-climate allergy clinics where G. domesticus is recognized as a clinically important species, SCIT with standardized storage mite extracts is also available. The AeDA/DGHNO-KHC position paper (Cuevas et al., Allergo J Int 2022) provides the most current evidence base for this independent storage mite immunotherapy approach.
Confirm G. Domesticus Sensitization
Request skin prick testing or serum specific IgE specifically for G. domesticus and Gly d 2 component alongside HDM testing to establish the precise sensitization profile.
Component-Resolved Diagnosis
Compare Gly d 2 versus Der p 2 IgE levels to determine whether G. domesticus sensitization is primary, co-existent, or cross-reactive β this determines whether G. domesticus-specific immunotherapy is needed independently.
Begin Species-Appropriate Immunotherapy
Start custom SLIT drops formulated with G. domesticus extract, combined with HDM extract if concurrent Dermatophagoides sensitization is also confirmed β not HDM-only.
Environmental Control Optimization
Parallel bedroom and living room humidity reduction, HEPA vacuuming of upholstered furniture, and replacement of heavily infested textiles reduces antigen challenge while immunotherapy modifies the immune response.
βEuropean evidence from maritime-climate allergy centers suggests 60-80% of storage mite-sensitized patients achieve significant symptom reduction with species-specific immunotherapy; the AeDA position paper supports this approachβ
Treat your Glycyphagus Domesticus (Furniture Mite): The 89.5% Sensitization Storage Mite allergy at the source
See if at-home sublingual allergy drops fit your allergies β a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing Β· Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living with Glycyphagus Domesticus Allergy
Managing G. domesticus allergy is a long-term commitment to indoor environmental quality in a domestic setting β different from the bedroom-focused approach of HDM allergy in that G. domesticus requires attention to the entire living space, particularly upholstered furniture in living rooms and family rooms where prolonged sitting creates sustained allergen exposure. The single most impactful insight for affected patients is understanding that their perennial rhinitis or poorly controlled asthma may be partially or predominantly driven by a storage mite that has not been included in their allergy evaluation. Requesting G. domesticus-specific testing is the critical first step that can transform management.
Request G. domesticus-specific testing
Standard allergy panels in most Western countries include only Dermatophagoides species. If you live in a maritime or coastal climate and have perennial rhinitis or asthma that responds poorly to HDM-focused treatment, specifically ask your allergist to add G. domesticus (and other storage mites) to your testing panel.
Whole-home humidity management
Unlike HDM allergen reduction, which focuses primarily on the bedroom, G. domesticus colonizes all soft furnishings throughout the home. Humidity management must extend to living rooms and family rooms where exposure to upholstered furniture is greatest.
Storage mite immunotherapy independence
If you have confirmed G. domesticus sensitization, ensure your immunotherapy formulation specifically includes this species β not just Dermatophagoides. This may require requesting a storage mite-specific formulation from your allergist rather than accepting a standard HDM-only protocol.
Seasonality of Glycyphagus Domesticus Allergy
G. domesticus allergy is fundamentally perennial β the mite inhabits indoor soft furnishings year-round, providing sustained allergen exposure regardless of season. However, mite populations do follow a seasonal pattern in temperate and maritime climates: populations peak in autumn and winter as homes are closed for heating, indoor humidity rises from limited ventilation, and condensation on cold walls creates favorable microhabitats. This creates a paradox common to all indoor allergen exposures: patients may feel worse in winter and autumn β when pollen is absent and outdoor air is clean β because indoor allergen concentrations from G. domesticus are actually highest during the cold months. Spring and summer ventilation with lower indoor humidity somewhat suppresses mite populations, though G. domesticus is hardier at lower humidity than some other dust mite species.
January - December
medium intensity
September - November
high intensity
December - February
high intensity
Preventing Glycyphagus Domesticus Exposure
Prevention of G. domesticus exposure focuses on controlling indoor humidity β the key driver of mite population establishment in domestic furnishings β and removing old, heavily infested upholstered items that harbor large mite populations. Unlike food-product storage mites, G. domesticus cannot be prevented by food handling changes; it requires household environmental modification.
Dehumidify living areas below 60-65% RH
G. domesticus requires indoor humidity above 65% to maintain populations; maintaining living room and bedroom humidity below 60% with dehumidifiers or HVAC control significantly reduces mite burden over 2-4 months.
HEPA vacuum upholstered furniture weekly
Regular HEPA vacuuming of sofas, armchairs, and ottomans removes G. domesticus and its allergen load from the surfaces closest to respiratory exposure; use a vacuum with a sealed HEPA filter system.
Replace old upholstered furniture in maritime climates
Sofas and chairs older than 10-15 years in high-humidity coastal homes have accumulated substantial organic debris supporting large G. domesticus populations; replacement with leather, vinyl, or regularly cleaned upholstery reduces the domestic reservoir.
Improve home ventilation in dry weather
Opening windows during low-humidity periods reduces indoor humidity and temporarily suppresses G. domesticus populations; cross-ventilation on dry days is a low-cost humidity reduction strategy.
Wash curtains and textile blinds monthly
Curtains and textile window coverings in humid rooms accumulate G. domesticus and their allergens; monthly washing at 60Β°C removes mites and reduces the soft furnishing allergen load.
Prognosis for Glycyphagus Domesticus Allergy
The prognosis for G. domesticus allergy is favorable when the correct diagnosis is established and species-specific immunotherapy is initiated alongside environmental humidity control. The 89.5% sensitization rate in the Northern Spain cohort reflects the extraordinary prevalence of this mite in maritime climate populations β a prevalence that creates both substantial disease burden and substantial opportunity for improvement through targeted intervention. Patients who receive correct diagnosis and G. domesticus-specific immunotherapy experience the same disease-modification benefits demonstrated for storage mite immunotherapy broadly: reduced symptom burden, decreased medication requirements, and improved quality of life. The most important prognostic factor β as with all storage mite allergies β is correct species identification, without which treatment targets the wrong allergen.
Key takeaways
G. domesticus achieved 89.5% sensitization in Northern Spain rhinoconjunctivitis patients β the highest single-species storage mite sensitization rate reported in any clinical cohort
Gly d 2 (NPC2) shares only ~40% identity with Der p 2 β HDM immunotherapy does not reliably cover G. domesticus sensitization
Unlike food-product storage mites, G. domesticus inhabits household furnishings β humidity control in living areas (not just the bedroom) is the primary avoidance strategy
Component-resolved diagnostics (Gly d 2 positive, Der p 2 negative) identifies monosensitized patients completely missed by HDM-only panels
G. domesticus is the most commonly missed allergen in perennial rhinitis patients who have a negative standard HDM panel β because their IgE is to Gly d 2, which doesn't cross-react with Der p 2, ODACTRA won't help them without adding G. domesticus-specific extract to their protocol.
Frequently Asked Questions
G. domesticus is taxonomically a storage mite (Glycyphagidae family) rather than a house dust mite (Pyroglyphidae family), despite inhabiting similar domestic environments. The key clinical difference is allergen profile: G. domesticus's major allergen Gly d 2 shares only approximately 40% amino acid identity with the dominant HDM allergen Der p 2 β below the ~60-70% threshold for significant IgE cross-reactivity. This means HDM immunotherapy products, including ODACTRA, do not reliably desensitize patients to G. domesticus. Epidemiologically, a patient can be sensitized to G. domesticus without being sensitized to Dermatophagoides, and vice versa. Ecologically, G. domesticus prefers upholstered furniture and carpets in humid homes rather than the mattress microenvironment where Dermatophagoides concentrations are highest.
Medical References
- [1]Cuevas M, SΓ‘nchez-Pastor S, Valero A, et al. Storage mite sensitization: clinical relevance and influence on allergic patients management. AeDA/DGHNO-KHC position paper. Allergo J Int. 2022;31:208-222.
- [2]SΓ‘nchez-Borges M, FernΓ‘ndez-Caldas E, Thomas WR, et al. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem. World Allergy Organ J. 2017;10:14.
- [3]Arlian LG, Platts-Mills TAE. The biology of dust mites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol. 2001;107:S422-S429.
- [4]WHO/IUIS Allergen Nomenclature Sub-Committee. Allergen Nomenclature Database. allergen.org. Accessed 2025.
- [5]Arlian LG, Neal JS, Vyszenski-Moher DL. Reducing relative humidity to control the house dust mite Dermatophagoides farinae. J Allergy Clin Immunol. 1999;104:852-856.
- [6]Kim JM, Lin SY, Suarez-Cuervo C, et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics. 2013;131:e1155-1167.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Glycyphagus Domesticus (Furniture Mite): The 89.5% Sensitization Storage Mite allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs β including the parts that are not flattering.
